NOTABLE FOR NEW ANONS

The Original Scientific papers posted by a group of Drs. Scientists from India, were removed and replaced with a completely different theory of the corona virus from Wuhan Communist China, the Lancet (bat theory) funded by the usual scum Bill & Melinda Gates Foundation and the WHO.

It was as though all listed and posted below had their careers, reputations and lively hoods threatened if they didn't remove the pending peer review theory from the India Scientists and those scientist on twitter.

>>8917310

Clearly a bioweaponized virus with 4 inserts of HIV

that came out of Wuhan…not some bat soup BS

>>8917310

>>8917312

>>8917314

Notable

A wealth of info…

http://mailstar.net/coronavirus.html?fbclid=IwAR3PGrgKfo1TE4xwUdkjOEj9EVKcyt7kkMP00Aow_uMKiP4m1D0pchQJVrI

https://archive.is/QIBmE

The official story about Coronavirus 2019 nCoV is that it “appears to have originated in the Huanan Seafood Wholesale Market in Wuhan, a Chinese city about 650 miles south of Beijing that has a population of more than 11 million people.” This tale has been officially reported as early as January 9th by CCP’s state-owned and operated news channel, Xinhuanet, New-type coronavirus causes pneumonia in Wuhan: expert, reported by local Chinese authorities to the US National Library of Medicine database, Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle and to the International Journal of Infectious Diseases database, The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China.

The article refers to statements provided by Dany Shoham, a former Israeli military intelligence officer who holds a doctorate in medical microbiology, and served as a senior analyst with Israeli military intelligence for biological and chemical warfare in the Middle East and worldwide from 1970 to 1991.“Coronaviruses (particularly SARS) have been studied in the Institute and are probably held therein”, Shohan reveals, as has anthrax, adding that “certain laboratories in the Institute have probably been engaged, in terms of research and development, in Chinese [biological weapons]. Work on biological weapons is conducted as part of a dual civilian-military research and is “definitely covert.” Troublingly, even a State Department report issued last year raised suspicions that China has been engaged in covert biological warfare work. “Information indicates that the People’s Republic of China engaged during the reporting period in biological activities with potential dual-use applications, which raises concerns regarding its compliance with the BWC,” the report said, adding that the United States suspects China failed to eliminate its biological warfare program as required by the treaty.

And yet another highly relevant study with the potential to capture the attention of biowarfare officials in United States defense departments is Discovery of a Rich Gene Pool of Bat SARS-related Coronaviruses Provides New Insights Into the Origin of SARS Coronavirus, published in November 2017, where Prof. Zhengli and her colleagues conducted cell entry studies which “demonstrated that three newly identified SARSr-CoVs [SARS-related coronaviruses] with different [spike] protein sequences are all able to use human ACE2 as the receptor, further exhibiting the close relationship between strains in this cave and SARS-CoV. This work provides new insights into the origin and evolution of SARS-CoV and highlights the necessity of preparedness for future emergence of SARS-like diseases” (emphasis added)….

All of the studies cited here appear related and interconnected, and considering the involvement of American defense agencies — in particular, the U.S. Defense Threat Reduction Agency which deals exclusively with matters pertaining to weapons of mass destruction and threat networks — there seems ample reason to be gravely concerned. And that concern remains whether there’s reason to suspect coronaviruses could be used by others as bioweapons of mass destruction, or that rogue, Deep State operatives within our own defense departments — colluding with Communists — are developing or have already developed a bioweapon of mass destruction.

In conclusion, though admittedly much investigation remains to be performed (especially into the numerous unanswered questions posed in this essay), it seems the likeliest source of origin for Coronavirus 2019-nCoV is the Wuhan National Biosafety Laboratory at the Wuhan Institute of Virology. Further, it appears to me that, at best, there may be concerted efforts to conceal the precise nature of the virus, its source, and the parties responsible, or that, at worst, the dissemination of the epidemic coronavirus is intentional. Could the actual RNA genome source, sequencing and recombination of the coronavirus already be known, and could its vaccine have already been developed? Could it already be patented? Essentially, is this latest global pandemic threat a Communist cover-up, or a pandemic bioweapon of mass destruction developed by the global Deep State?

>>8917312

Coronavirus could attack immune system like HIV by targeting protective cells

https://www.scmp.com/news/china/society/article/3079443/coronavirus-could-target-immune-system-targeting-protective

CRISPR/ 4 Inserts of HIV would explain this, correct? And breakdown of Lymphocytes, Pathogenic T cell destruction, etc?

More than just 10th grade biology here

>>8917693

Thank You…

No one yet has convinced me that HIV was not a bioweapon

>>8917466

>>8917693

>>8917312

Interleukin 6 Inhibitors

PS…I don't trust any paper from the Lancet

Interleukin-6 inhibitor/ inhibitors

https://www.sciencedirect.com/science/article/abs/pii/S0163725813001939

Associate editor: B. Teicher

Targeting interleukin-6 in inflammatory autoimmune diseases and cancers

Author links open overlay panelXinYaoaJiaqiHuangaHaihongZhongaNanShencRaffaellaFaggionibMichaelFungaYihongYaoa

https://doi.org/10.1016/j.pharmthera.2013.09.004

Get rights and content

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine with significant functions in the regulation of the immune system. As a potent pro-inflammatory cytokine, IL-6 plays a pivotal role in host defense against pathogens and acute stress. However, increased or deregulated expression of IL-6 significantly contributes to the pathogenesis of various human diseases. Numerous preclinical and clinical studies have revealed the pathological roles of the IL-6 pathway in inflammation, autoimmunity, and cancer. Based on the rich body of studies on biological activities of IL-6 and its pathological roles, therapeutic strategies targeting the IL-6 pathway are in development for cancers, inflammatory and autoimmune diseases. Several anti-IL-6/IL-6 receptor monoclonal antibodies developed for targeted therapy have demonstrated promising results in both preclinical studies and clinical trials. Tocilizumab, an anti-IL-6 receptor antibody, is effective in the treatment of various autoimmune and inflammatory conditions notably rheumatoid arthritis. It is the only IL-6 pathway targeting agent approved by the regulatory agencies for clinical use. Siltuximab, an anti-IL-6 antibody, has been shown to have potential benefits treating various human cancers either as a single agent or in combination with other chemotherapy drugs. Several other anti-IL-6-based therapies are also under clinical development for various diseases. IL-6 antagonism has been shown to be a potential therapy for these disorders refractory to conventional drugs. New strategies, such as combination of IL-6 blockade with inhibition of other signaling pathways, may further improve IL-6-targeted immunotherapy of human diseases.

Full Length article

Keywords

Interleukin-6

Autoimmune

Inflammation

Cancer

Targeted therapy

Monoclonal antibody

Abbreviations

AMLacute myeloid leukemia

COPDchronic obstructive pulmonary disease

CRCcolorectal cancer

CRPC-reactive protein

CSCcancer stem cells

DLTdose-limiting toxicity

EAEexperimental autoimmune encephalitis

EGFRepidermal growth factor receptor

IBDinflammatory bowel diseases

IFNinterferon

IL-6interleukin-6

IL-6RIL-6 receptor

mAbmonoclonal antibody

MMmultiple myeloma

MSmultiple sclerosis

MTXmethotrexate

NSCLCnon-small cell lung cancer

RArheumatoid arthritis

RCCrenal cell carcinoma

sgp130soluble gp130

sIL-6Rsoluble IL-6R

SJIAsystemic juvenile idiopathic arthritis

SLEsystemic lupus erythematosus

SOCSsuppressor of cytokine signaling

SScsystemic sclerosis

STATsignal transducers and activators of transcription

TAMtumor-associated macrophage

TLRToll-like receptor

TNFtumor necrosis factor

VEGFvascular endothelial growth factor

View full text

Copyright © 2013 Elsevier Inc. All rights reserved.

Tocilizumab, an anti-IL-6 receptor antibody, is effective in the treatment of various autoimmune and inflammatory conditions notably rheumatoid arthritis. It is the only IL-6 pathway targeting agent approved by the regulatory agencies for clinical use. Siltuximab, an anti-IL-6 antibody, has been shown to have potential benefits treating various human cancers either as a single agent or in combination with other chemotherapy drugs. Several other anti-IL-6-based therapies are also under clinical development for various diseases. IL-6 antagonism has been shown to be a potential therapy for these disorders refractory to conventional drugs. New strategies, such as combination of IL-6 blockade with inhibition of other signaling pathways, may further improve IL-6-targeted immunotherapy of human diseases.

Possible cure all for a great deal of illnesses/cancer…If an inhibitor is found.

Interferon??? Is Interferon a More suitable choice???

I would never trust a Bill Gates or Fauci recommended drug like Trial bomber Remdesivir

Patent: Communist China and manufactured there. Gilead